{
  "Variants Include": [
    {
      "Gene": "ND5",
      "variants": [
        {
          "HGVS": "m.12397A>G",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "A",
            "alt": "G",
            "position": "12397"
          },
          "Protein Change": {
            "ref": "T",
            "alt": "A",
            "position": "21"
          },
          "Description in input context": "m.12397A>G (p.T21A)"
        }
      ]
    },
    {
      "Gene": "ND6",
      "variants": [
        {
          "HGVS": "m.14319T>C",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "T",
            "alt": "C",
            "position": "14319"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "D",
            "position": "119"
          },
          "Description in input context": "m.14319T>C (p.N119D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0015658"
  },
  "Experiment Method": [
    {
      "Assay Method": "DNA sequencing",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient and mother",
        "Description": "Sequence analysis of mtDNA in patient and mother."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "m.12397A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Missense mutation causing threonine to alanine at position 21.",
          "Result Description": "Missense mutation in ND5 gene identified."
        },
        {
          "Variant": "m.14319T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Missense mutation causing asparagine to aspartic acid at position 119.",
          "Result Description": "Missense mutation in ND6 gene identified."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Patient and mother samples analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Superoxide anion radical measurement",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient",
        "Description": "Measurement of superoxide anion radical production using an inhibitor of complex I."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "m.12397A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Enhanced superoxide production abrogated by complex I inhibitor.",
          "Result Description": "Enhanced superoxide anion radical production observed, which was reduced upon treatment with a complex I inhibitor."
        },
        {
          "Variant": "m.14319T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Enhanced superoxide production abrogated by complex I inhibitor.",
          "Result Description": "Enhanced superoxide anion radical production observed, which was reduced upon treatment with a complex I inhibitor."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal levels of superoxide anion radical production under baseline conditions.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Elevated levels of superoxide anion radical production compared to controls.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Enzyme kinetic analysis",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient",
        "Description": "Enzyme kinetic analysis of NADH:ubiquinone oxidoreductase activity."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "m.12397A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Changes in substrate affinity for complex I.",
          "Result Description": "Alterations in the enzyme activity and substrate affinity of NADH:ubiquinone oxidoreductase were observed."
        },
        {
          "Variant": "m.14319T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Changes in substrate affinity for complex I.",
          "Result Description": "Alterations in the enzyme activity and substrate affinity of NADH:ubiquinone oxidoreductase were observed."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal enzyme activity and substrate affinity under baseline conditions.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Altered enzyme activity or substrate affinity compared to controls.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}